Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The IMG Institute of Medical Genome Research (IMG) was a Vienna-based management and consultancy enterprise focused on advancing genomics and systems biology research. Founded in 2002, the company played a central role in planning and managing the "IMGuS" (Institute for Medical Genome Research and Systems Biology) research program, which was funded by the Austrian government. IMG's activities centered on linking frontier research in IT, life sciences, and medicine to develop personalized treatment schemes, particularly in the areas of oncology (prostate cancer) and liver diseases (steatohepatitis). The company facilitated international collaborations and public-private partnerships, contributing to numerous patent applications and scientific publications in the field of molecular medicine.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on IMG Institute of Medical Genome Research.